> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Making Progress on Clinical Trial Diversity: Buch
- URL: https://www.fdaweb.com/fda-making-progress-on-clinical-trial-diversity-buch/
- Published: 2016-01-14T12:00:00.000Z
- Updated: 2026-09-15T02:27:36.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134441

> CBER associate director for medicine **Barbara Buch** says that the agency has taken “important steps to support the inclusion of diverse populations in clinical trials.” Writing in an *FDA Voice* blog [post](http://blogs.fda.gov/fdavoice/index.php/2016/01/progress-and-collaboration-on-clinical-trials/?source=govdelivery&utm%5Fmedium=email&utm%5Fsource=govdelivery), Buch says the agency is implementing Congress’ directive in the FDA Safety and Innovation Act to look more closely at the sex, age, and race/ethnicity data that are collected in clinical trials.  
>  
> The agency, she writes, published an 8/2015 action plan intended to address improving the quality and comprehensiveness of demographic subgroup data collection, identifying and eliminating barriers to increased participation in clinical trials, and improving subgroup data transparency.  
>  
> She describes progress made in each of the three areas and says the next milestone will be a 2/29 public meeting on the topic.